Additionally, we found the protein levels of NEDD4L were significantly up-regulated in the NASH group compared with the control group, which was both verified in the human NASH subjects, mouse NASH models and hepatocytes stimulated with PA (Supplementary Fig. 2a–e). This evidence concerns the gene NEDD4L and metabolic dysfunction-associated steatohepatitis.